GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

Characterization of F. tularensis Virulence Genes

$220,894
Karl E Klose · University Of Texas San Antonio · P01 · FY2009 · AI

Evaluating STI screening and antimicrobial resistance in Neisseria gonorrhoeae among PrEP users in Vietnam

$220,833
Jeffrey David Klausner · University Of Southern California · R21 · FY2021 · AI

Generation of recombinant thiopeptides to target antimicrobial-resistant bacteria

$220,814
James A Wells · University Of California, San Francisco · R21 · FY2014 · AI

Apply an imaging flow cytometry method to screen chemical libraries for identifying and repurposing novel drugs against coccidioidomycosis

$220,750
Chiung-Yu Hung · University Of Texas San Antonio · R21 · FY2021 · AI

A role of material stiffness in ophthalmic biofilm formation and virulence of Pseudomonas aeruginosa

$220,683
Dacheng Ren · Syracuse University · R21 · FY2016 · EY

Sensitive Treponema pallidum genome recovery through tiling amplicon sequencing

$220,625
Alexander L Greninger · University Of Washington · R21 · FY2025 · AI

Infectious Disease Training in Clinical Investigation

$220,549
James R Johnson · University Of Minnesota · T32 · FY2011 · AI

New Tools for the interpretation of Pathogen Genomic Data with a focus on Mycobacterium tuberculosis

$220,530
Maha Farhat · Harvard Medical School · K01 · FY2018 · ES

Computational Modeling /Design of Antimicrobial Peptides

$220,518
Yiannis Kaznessis · University Of Minnesota · R01 · FY2006 · GM

Design of Novel Linear Cationic Antimicrobial Peptides

$220,500
John F Blazyk · Ohio University Athens · R15 · FY2006 · AI

Tuberculosis in diabetic guinea pigs

$220,500
Randall J Basaraba · Colorado State University · R21 · FY2012 · AI

Targeting persistent M. tuberculosis through the inhibition of its aldolase

$220,500
Mary Jackson · Colorado State University · R21 · FY2009 · AI

Molecular and Structural Bases of Polymyxin Resistance

$220,500
Washington University · R01 · FY2004 · AI

Regulation of morphogenesis in C. albicans

$220,102
James B. Konopka · State University New York Stony Brook · R01 · FY2017 · AI

Alternative Genetic Selection in Bacillus anthracis and Francisella tularensis

$219,989
George C. Stewart · University Of Missouri-Columbia · R21 · FY2008 · AI

Purine biosynthesis as a therapeutic target for Helicobacter pylori infection

$219,960
Joanna B. Goldberg · Emory University · R21 · FY2013 · AI

Imaging the struggle for nutrient metal between host and pathogen

$219,960
Eric P Skaar · Vanderbilt University · R21 · FY2013 · AI

GINGIVAL EPITHELIAL CELL ANTIMICROBIAL PEPTIDES

$219,958
Case Western Reserve University · R01 · FY2000 · DE

Slippery Nanoemulsion-Infused Polymer Coatings that Prevent Bacterial Fouling and Block Bacterial Virulence

$219,930
David M Lynn · University Of Wisconsin-Madison · R21 · FY2023 · EB

Bioprospecting antibiotics in the fungal secondary metabolome

$219,905
Lindsey Neil Shaw · University Of South Florida · R21 · FY2014 · AI

Pyocins as antibacterials to treat Pseudomonas aeruginosa infections

$219,891
Joanna B. Goldberg · Emory University · R21 · FY2023 · AI

INTERDISCIPLINARY PROGRAM IN BACTERIAL PATHOGENESIS

$219,837
Ferric C Fang · University Of Washington · T32 · FY2018 · AI

GENE EXPRESSION OF P AERUGINOSA DURING BIOFILM DEVELOPME

$219,826
Montana State University (Bozeman) · R01 · FY2002 · AI

Mycoplasma genitalium Susceptibility and Treatment

$219,745
Lisa E Manhart · University Of Washington · U19 · FY2007 · AI

GrgA: Key Regulator of Chlamydial Physiology and potential Antichlamydial Target

$219,741
Huizhou Fan · Rbhs-Robert Wood Johnson Medical School · R21 · FY2016 · AI